Yüklüyor......
Treatment of high-risk neuroblastoma
Although high-dose chemotherapy and autologous stem cell transplantation (HDCT/autoSCT) have improved the prognosis for patients with high-risk neuroblastoma (NB), event-free survival rates remain in the range of 30 to 40%, which is unsatisfactory. To further improve outcomes, several clinical trial...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Korean Pediatric Society
2012-04-01
|
| Seri Bilgileri: | Korean Journal of Pediatrics |
| Konular: | |
| Online Erişim: | http://kjp.or.kr/upload/pdf/kjped-55-115.pdf |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|